Chordate Medical is a medical technology company that has developed, patented and CE-marked a neuromodulation and drug-free treatment technology for chronic migraine and chronic nasal congestion (rhinitis), Ozilia™ Migraine. The treatment has clinically proven efficacy according to a recent study, and is marketed in selected markets in the EU and the Middle East. Chordate Medical is listed on Nasdaq First North Growth Market Stockholm.


Health Care

Medical Devices

Therapeutics

Chordate Medical AB

Chordate Medical AB's headquarters in Stockholm, Sweden

Description

People (5)

Niklas Lindecrantz

Caroline Lundgren Brandberg

Henrik Rammer

Gunilla Lundmark

Tommy Hedberg

Jobs